Systematic Financial Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-6,635
| Closed | -$318K | – | 466 |
|
|
2020
Q2 | $318K | Sell |
6,635
-3,285
| -33% | -$157K | 0.02% | 319 |
|
|
2020
Q1 | $456K | Sell |
9,920
-630
| -6% | -$29K | 0.03% | 188 |
|
|
2019
Q4 | $634K | Buy |
10,550
+1,025
| +11% | +$61.6K | 0.02% | 292 |
|
|
2019
Q3 | $539K | Sell |
9,525
-7,200
| -43% | -$407K | 0.02% | 353 |
|
|
2019
Q2 | $931K | Buy |
+16,725
| New | +$931K | 0.04% | 341 |
|
|
2018
Q3 | – | Sell |
-19,030
| Closed | -$1.44M | – | 684 |
|
|
2018
Q2 | $1.44M | Sell |
19,030
-4,925
| -21% | -$373K | 0.04% | 367 |
|
|
2018
Q1 | $1.26M | Sell |
23,955
-2,050
| -8% | -$108K | 0.03% | 499 |
|
|
2017
Q4 | $1.39M | Sell |
26,005
-175
| -0.7% | -$9.35K | 0.03% | 460 |
|
|
2017
Q3 | $1.56M | Buy |
+26,180
| New | +$1.56M | 0.03% | 391 |
|